Retinol Alone Is Not Enough: Why Your Night Cream Needs a Collagen Signal

Retinol is the most studied topical active in skincare. Decades of evidence. Thousands of papers. No serious dermatologist disputes its efficacy for wrinkle reduction, collagen stimulation, and cell turnover.

But there is a question that most retinol products do not address: what happens to the new cells once they arrive?

Retinol accelerates the rate at which your skin produces fresh cells and pushes older, damaged cells to the surface. That is its primary function. It is very good at it. The problem is that new cells arriving into a degraded extracellular matrix — depleted collagen, fragmented elastin, weakened structural scaffolding — are not arriving into an environment that supports them. They are moving into a house with no framework.

This is why Dr Alison Jamieson formulated the Ultimate A Night Cream with retinol and Matrixyl synthe'6 together. Not as a marketing pairing. As a biological one.

What Retinol Actually Does at the Cellular Level

Retinol works by binding to retinoid receptors in the skin — specifically RAR and RXR receptors — which modulate gene expression. The downstream effects are well documented: increased epidermal cell turnover, upregulated collagen I and III synthesis, and reduced activity of matrix metalloproteinases (the enzymes that break collagen down).

For photodamaged skin — the kind that 40 years of Queensland sun produces — this is exactly the intervention that is needed. The accumulated UV damage that drives fine lines, uneven texture, and loss of firmness is, at its core, a problem of impaired cell renewal and collagen degradation. Retinol addresses both.

But retinol's collagen stimulation works through a single signalling pathway. It upregulates production, yes. It does not, however, directly signal for the six specific types of collagen and structural proteins that form the complete dermal matrix. That is where the second active in this formulation becomes relevant.

Matrixyl synthe'6: Six Pathways, One Peptide

Matrixyl synthe'6 (Palmitoyl Tripeptide-38) is a signalling peptide that mimics the biological sequence your skin uses to trigger matrix production. Where retinol's collagen effect is a general upregulation, Matrixyl synthe'6 is specific. Published research demonstrates that it simultaneously stimulates the production of six major structural components of the dermal matrix: collagen I, collagen III, collagen IV, fibronectin, hyaluronic acid, and laminin-5.

These are not interchangeable proteins. Each plays a distinct structural role. Collagen I provides tensile strength. Collagen III supports elasticity and is the first collagen type laid down during wound healing. Collagen IV forms the basement membrane that anchors the epidermis to the dermis. Fibronectin acts as the cellular adhesion scaffold. Hyaluronic acid maintains hydration volume within the matrix. Laminin-5 anchors epithelial cells to the underlying connective tissue.

A formulation that stimulates only collagen I — as many single-peptide products do — is addressing one dimension of a six-dimensional problem. The dermal matrix is an integrated structure. Restoring it meaningfully requires signalling across multiple pathways simultaneously.

The Logic of Pairing Them

Dr Jamieson's formulation rationale is straightforward once you understand what each active does.

Retinol clears the way. It accelerates the removal of photodamaged cells, stimulates fresh cell production, and begins the process of collagen renewal. Think of it as the demolition and rebuilding crew — it strips away what is damaged and signals for new construction.

Matrixyl synthe'6 provides the architectural blueprint. It tells the skin precisely which structural proteins to produce and in what combination, ensuring that the new matrix being built is complete and integrated rather than patchy.

When the two work together in a single PM step, the skin receives a coordinated instruction set: turn over damaged cells, produce new ones, and build them a proper structural environment to function within. Neither active alone delivers both halves of that equation.

This is protocol logic, not ingredient stacking. Each active was selected because it addresses a specific gap that the other does not.

Encapsulated Delivery

The retinol in the Ultimate A Night Cream is encapsulated using hydroxypropyl cyclodextrin, which means it is contained within a protective molecular shell that controls its release.

Standard free-form retinol hits the skin all at once, which is partly why it causes irritation. The entire dose is delivered in a single wave, overwhelming the skin's capacity to process it without a reactive response. Encapsulated retinol releases gradually, extending the active's contact time with target cells while reducing the peak concentration at any given moment.

The practical outcome: encapsulated retinol maintains greater stability and a longer active window than free-form retinol. That means the active is working for longer, at a lower peak concentration, with less irritation. More benefit. Less reaction. Better compliance.

Compliance is a clinical concern that Dr Jamieson takes seriously. The best retinol formulation in the world is useless if people stop using it after two weeks because their skin is scaling. The encapsulated delivery system means that more patients can maintain consistent use throughout their protocol — and consistency is where the real results compound.

What This Means for PM Protocol Design

The Ultimate A Night Cream is applied as part of the PM Protocol, and the timing is not arbitrary. Retinol is photosensitive and degrades under UV exposure, which makes evening application essential. But there is a deeper reason: skin's repair and renewal processes peak during sleep. Cell turnover accelerates. Collagen synthesis increases. The biological environment is optimised for the kind of work that retinol and Matrixyl synthe'6 do.

By positioning this cream in the PM Protocol, Dr Jamieson ensures that the retinol-peptide system works during the window when your skin is most receptive to it. The encapsulated delivery extends the retinol's active release across that window, while Matrixyl synthe'6 provides the structural signalling that makes the new cell production meaningful.

In the morning, The Protocol shifts to protection. The Day Cream SPF 15 defends the skin that the PM Protocol has just worked to repair. This is the logic of sequential protocol design: repair at night, protect by day, compound the results over weeks and months.

Two Actives, Two Pathways, One Step

The skincare industry tends to treat retinol as a standalone solution. Apply retinol. Wait for results. Manage the irritation.

Dr Jamieson's approach is different. Retinol is not the endpoint — it is one half of a coordinated system. The other half is a signalling peptide that ensures the structural rebuilding retinol initiates is complete, specific, and architecturally sound.

That is what the Ultimate A Night Cream delivers in a single PM step. Not a retinol product with added extras. A formulation designed so that two clinically validated actives address two distinct biological requirements — cell renewal and matrix reconstruction — simultaneously.

The evidence supports each ingredient independently. The formulation logic supports them together. And the PM Protocol positions them where your skin is most capable of using them.

⚕️ Note: Matrixyl synthe'6 (Palmitoyl Tripeptide-38) data references published in vitro studies on six-pathway matrix stimulation. Retinol mechanism and receptor binding reflect established dermatological literature. Individual results vary. Consult your prescribing doctor for personalised advice.

Dr Alison Jamieson — MBBS, FRACGP, Dip Derm — formulates all Aliangé products based on over 40 years of clinical experience treating Australian skin.

Internal links: - Ultimate A Night Cream — $130 - Revitalize Anti-Ageing Day Cream SPF 15 — $90 - The Protocol - Take the Skin Quiz

⚕️ Medical claims flagged for Dr Jamieson review: - Matrixyl synthe'6 simultaneously stimulates collagen I, III, IV, fibronectin, hyaluronic acid, and laminin-5 — verify against published in vitro data - Retinol binds RAR/RXR receptors to modulate gene expression for cell turnover and collagen I/III — standard dermatological literature, low risk - Hydroxypropyl cyclodextrin encapsulation claims (extended release, stability) — verify specific delivery mechanism claims - Matrix metalloproteinase suppression by retinol — verify this is accurately stated